U.S. Musculoskeletal Rehabilitation Devices Market $9.58B

Market Outlook

By 2032, the U.S. Musculoskeletal Rehabilitation Devices Market is projected to reach approximately USD 9.58 billion, expanding at a CAGR of 9.85% during the forecast period 2027–2032. The market was valued at USD 5.45 billion in 2026, with historical analysis covering 2023 to 2025. The market increased from approximately USD 4.18 billion in 2023 to USD 4.55 billion in 2024 and USD 4.96 billion in 2025, reflecting strengthening orthopedic procedure volumes, rehabilitation utilization, home-recovery adoption, digital monitoring, and demand for technologies that restore mobility while reducing dependence on high-cost facility-based therapy. Monetary values in this report are expressed in USD billions.

The U.S. musculoskeletal rehabilitation devices industry sits at the intersection of orthopedics, physical therapy, pain management, sports medicine, aging care, and post-surgical recovery. Its commercial foundation is unusually broad because musculoskeletal disorders affect patients across virtually every age group. More than 53 million U.S. adults have reported diagnosed arthritis, while chronic pain affects almost one-quarter of the adult population. Back, lower-limb, upper-limb, joint, tendon, and soft-tissue disorders collectively create a substantial recurring pool of patients requiring therapeutic exercise, bracing, neuromuscular stimulation, joint mobilization, gait retraining, pain-control modalities, and home rehabilitation equipment.

Demand is increasingly moving beyond conventional clinic-based exercise equipment toward a connected recovery ecosystem. Smart braces, sensor-enabled range-of-motion systems, remote therapeutic monitoring platforms, anti-gravity rehabilitation systems, digitally guided home exercise programs, portable electrotherapy, robotic gait technologies, and data-generating rehabilitation devices are changing how orthopedic recovery is managed. The commercial value of these systems is increasingly tied not only to clinical performance but also to their ability to document adherence, reduce unnecessary visits, support earlier discharge, extend rehabilitation into the home, and identify patients who are deviating from expected recovery trajectories.

The U.S. joint-replacement ecosystem provides another major demand foundation. The American Joint Replacement Registry now contains data covering more than 4.4 million hip and knee arthroplasty procedures performed from 2012 through 2024. Every major expansion in hip, knee, shoulder, spine, ligament reconstruction, and sports-medicine intervention creates downstream rehabilitation requirements. As more orthopedic procedures migrate to ambulatory and short-stay settings, responsibility for functional recovery increasingly shifts toward outpatient therapy clinics, home-based devices, digital engagement systems, and patient-operated recovery technologies.

Hospital and physician procurement behavior is therefore moving toward episode economics rather than equipment acquisition cost alone. A rehabilitation technology capable of supporting faster ambulation, earlier range-of-motion recovery, fewer therapist-intensive visits, better adherence, or lower risk of readmission can justify a premium price when evaluated across an orthopedic care episode. This economic logic will be one of the most important forces shaping the U.S. market through 2032.

Introduction

According to the U.S. Musculoskeletal Rehabilitation Devices Market Report, the industry covers medically directed technologies used to restore movement, strength, stability, range of motion, functional independence, gait, and pain-controlled activity following musculoskeletal disease, injury, surgery, trauma, or progressive mobility impairment. The market includes therapeutic exercise systems, electrotherapy and neuromuscular stimulation devices, orthopedic rehabilitation braces and supports, continuous passive-motion and joint-mobilization systems, gait and body-weight-support equipment, anti-gravity systems, and connected or robotic rehabilitation platforms.

The market scope is intentionally centered on rehabilitative devices rather than orthopedic implants. Joint implants, spine implants, trauma fixation hardware, diagnostic imaging systems, pharmaceutical pain therapies, and unrestricted consumer fitness equipment fall outside the core market unless a product is directly incorporated into a prescribed rehabilitation pathway. This distinction is commercially important because procurement channels, reimbursement rules, regulatory pathways, replacement cycles, and buyers for rehabilitation equipment differ materially from those governing surgical implants.

The addressable patient pool is substantial. Diagnosed arthritis affects approximately 21.2% of U.S. adults, while arthritis prevalence rises sharply with age and exceeds half of adults in the oldest age groups. Chronic pain affected 24.3% of U.S. adults in 2023, and high-impact chronic pain that frequently limits work or life activities affected 8.5%. Musculoskeletal rehabilitation also intersects with disability management: mobility difficulty remains one of the most common functional disability categories in the United States, and approximately one in four older Americans experiences a fall each year.

These patient-level trends translate into an extensive rehabilitation delivery infrastructure. The United States had approximately 283,700 physical therapists in 2025, and employment is projected to rise about 12% through 2035. Around 36% of physical therapists work in offices of physical, occupational, and speech therapists, approximately 26% work in hospitals, and about 11% work in home healthcare. Physical therapist assistants are growing even faster, reflecting provider attempts to expand treatment capacity and manage the labor economics of rehabilitation.

The economic structure of musculoskeletal rehabilitation is consequently becoming more distributed. Acute hospitals initiate recovery following major orthopedic surgery or trauma, but the majority of rehabilitation duration occurs downstream in outpatient physical therapy, orthopedic practices, rehabilitation hospitals, skilled nursing settings, athletic medicine programs, or patients’ homes. Device manufacturers that can operate across several of these settings are better positioned than companies dependent on a single institutional channel.

Another defining feature is reimbursement fragmentation. Some rehabilitation technologies are purchased as hospital capital equipment; others are reimbursed through DMEPOS pathways, bundled into therapy services, rented to patients, purchased by orthopedic groups, or supported through remote therapeutic monitoring. Medicare rules for braces, prosthetic and orthotic devices, rehabilitation therapy, DME, and digitally monitored services therefore have a direct effect on market access. Commercial insurers, workers’ compensation plans, Medicare Advantage organizations, employer health plans, and cash-pay rehabilitation also create materially different adoption economics.

From 2027 through 2032, the strategic center of gravity will shift from isolated rehabilitation devices to measurable recovery platforms. The winning technologies will increasingly demonstrate what happened between clinical encounters: whether a brace was worn, whether prescribed range-of-motion targets were reached, whether therapeutic exercise was completed, whether pain or function deteriorated, and whether the patient requires clinician intervention.

Key Market Drivers: What’s Fueling the U.S. Musculoskeletal Rehabilitation Devices Market Boom?

The first major driver is the scale and persistence of U.S. musculoskeletal disease. Arthritis alone affects tens of millions of adults and remains one of the country’s most important causes of activity limitation. Osteoarthritis, degenerative joint disease, chronic back pain, tendon disorders, shoulder dysfunction, knee instability, and mobility impairment generate recurring rehabilitation demand rather than one-time treatment episodes. Unlike device categories dependent on a narrow surgical procedure, musculoskeletal rehabilitation participates across conservative care, prehabilitation, post-surgical recovery, chronic disease management, sports medicine, geriatric care, and return-to-work programs.

The second driver is the continuing expansion of orthopedic procedural activity. Hip replacement, knee replacement, shoulder reconstruction, ACL repair, rotator cuff surgery, spine surgery, fracture management, and other musculoskeletal interventions require structured recovery after treatment. The national joint-replacement registry has accumulated more than 4.4 million hip and knee procedures through 2024, demonstrating the scale of one of the largest rehabilitation-generating orthopedic procedure categories. As surgical techniques improve and more patients become candidates for intervention, downstream demand for bracing, cold and compression therapy, strengthening, joint mobilization, gait retraining, and connected recovery systems expands accordingly.

The third driver is outpatient migration. Orthopedic surgery continues to move from traditional inpatient admission toward hospital outpatient departments and ambulatory surgery centers. Shorter length of stay reduces institutional rehabilitation time and transfers a larger portion of recovery to outpatient practices and homes. This strengthens demand for portable devices, patient-friendly controls, remote monitoring, home exercise systems, compact electrotherapy, post-operative braces, and equipment that can move with the patient across care settings.

The fourth driver is rehabilitation labor economics. The United States has a large physical therapy workforce, but clinical labor remains expensive and capacity is not unlimited. Physical therapists earned a median annual wage above USD 100,000 in 2025, while demand for PTs and assistants is projected to grow substantially faster than total U.S. employment. Health systems and independent clinics therefore have a financial incentive to use technologies that allow clinicians to supervise more patients, collect objective data without constant manual assessment, automate repetitive therapeutic movement, and transition appropriate recovery activities into the home.

The fifth driver is the emergence of reimbursement structures supporting connected rehabilitation. Medicare’s remote therapeutic monitoring framework now explicitly includes musculoskeletal monitoring, while new 2026 coding expanded options for shorter monitoring periods and treatment-management services. These changes improve the commercial logic for technologies that capture adherence, therapy response, activity, and musculoskeletal recovery metrics. The result is a stronger business case for integrating connected devices with provider dashboards rather than selling hardware as a disconnected one-time product.

The sixth driver is expanding coverage for clinically appropriate orthotic management. Medicare knee-orthosis policy was revised for 2026 to recognize coverage pathways for certain ambulatory beneficiaries with tibiofemoral osteoarthritis, pain, or reduced mobility and function. This is strategically important because osteoarthritis bracing sits between conservative management and surgery. Expanded clinical recognition of unloading, stabilization, and functional-support technologies can increase utilization among older adults who are attempting to delay surgery or maintain mobility.

An additional demand catalyst is fall prevention and age-related functional decline. Approximately one in four older adults falls annually in the United States. Lower-extremity weakness, arthritis, balance deficits, post-operative deconditioning, and fear of falling can all lead to reduced activity, which in turn accelerates muscle loss and disability. Strengthening devices, balance systems, gait-training equipment, support devices, and home rehabilitation products therefore have growing relevance beyond traditional post-operative care.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in musculoskeletal rehabilitation is increasingly centered on the ability to quantify recovery rather than simply deliver therapy. Conventional devices often provide resistance, support, stimulation, or passive motion without generating objective evidence about how the patient is progressing. Connected systems are changing this model by embedding sensors that measure range of motion, exercise completion, wear time, repetition count, loading, gait parameters, or compliance.

Smart orthopedic bracing is emerging as one of the clearest examples. Sensor-equipped post-operative knee braces can measure joint motion and transmit recovery information to applications and provider portals. This converts a traditional brace from a passive support device into a data-generating component of the orthopedic episode. For surgeons and physical therapists, the value lies in identifying inadequate movement, poor adherence, or unexpected recovery patterns before the next scheduled visit.

Electrotherapy is also becoming more portable and personalized. Neuromuscular electrical stimulation, transcutaneous electrical nerve stimulation, therapeutic ultrasound, combination electrotherapy, functional electrical stimulation, thermal modalities, and compression technologies are increasingly designed for both clinical and home use. The strategic opportunity is strongest where devices can transition from supervised treatment to prescribed self-management without creating excessive training requirements.

Robotic and computer-assisted rehabilitation technologies represent a smaller revenue base but a faster innovation cycle. Robotics can provide repetitive, measurable movement while reducing the physical burden placed on therapists. Anti-gravity treadmills, body-weight-support systems, sensor-based gait platforms, robotic lower-extremity systems, and instrumented rehabilitation equipment are particularly relevant to complex orthopedic recovery, severe deconditioning, high-performance sports rehabilitation, and patients who cannot initially tolerate normal weight-bearing loads.

Another important innovation area is digital musculoskeletal rehabilitation. Remote therapeutic monitoring creates a bridge between medical devices, software, and reimbursement. Devices that automatically transmit adherence or motion data offer a fundamentally different commercial proposition from a standalone home exercise product. They can become part of a recurring service workflow in which clinicians review patient progress, intervene selectively, and document management activity.

Artificial intelligence will increasingly sit above these connected systems. The near-term opportunity is less about replacing physical therapists and more about helping clinicians prioritize patients. Motion analysis, computer vision, recovery benchmarking, predictive risk scoring, and automated identification of deviation from expected functional milestones could allow one clinician to manage a larger caseload while focusing direct attention on patients at higher risk.

Manufacturers are also investing more heavily in comfort, usability, lightweight materials, simplified donning and doffing, and patient-specific fitting. Rehabilitation adherence is strongly influenced by whether a patient will actually use the technology outside the clinic. Devices that perform well technically but are uncomfortable, complicated, or disruptive to daily living can lose real-world effectiveness. Human-factor engineering is consequently becoming as commercially important as mechanical sophistication.

Segmentation Insights

The U.S. Musculoskeletal Rehabilitation Devices Market is segmented on the basis of product category, application, end user, technology type, and region.

By Product Category

Therapeutic Exercise and Strengthening Equipment

Therapeutic exercise and strengthening equipment formed the largest product category in 2026, representing approximately 23.5% of the market, equivalent to USD 1.28 billion. The segment includes resistance systems, therapeutic exercise stations, balance trainers, rehabilitation cycles, treatment tables with exercise functionality, strength-testing equipment, hand-therapy systems, functional training devices, and clinically oriented exercise accessories.

Its leadership reflects the central role of progressive movement in nearly every musculoskeletal rehabilitation pathway. Physical therapy offices constitute the largest employment setting for U.S. physical therapists, making outpatient rehabilitation clinics a high-volume purchasing channel. The segment is relatively mature, but growth is supported by replacement demand, clinic expansion, evidence-based strengthening protocols, sports rehabilitation, and growing adoption of compact systems that can be used in outpatient and home environments.

Electrotherapy and Pain-Management Devices

Electrotherapy and pain-management technologies accounted for approximately 19.8%, or USD 1.08 billion, in 2026. This category includes TENS, NMES, electrical muscle stimulation, combination electrotherapy systems, therapeutic ultrasound, heat and cold systems, light-based therapeutic modalities, and related pain-control technologies.

The patient pool is substantial because 24.3% of American adults reported chronic pain in 2023. Musculoskeletal pain is particularly relevant because back, joint, upper-extremity, and lower-extremity symptoms frequently require repeated conservative management. The fastest opportunities are emerging in portable technologies that can be transitioned into home care and devices that combine more than one therapeutic modality in a single platform.

Orthopedic Rehabilitation Braces and Supports

Orthopedic rehabilitation braces and supports generated approximately USD 1.05 billion in 2026, representing 19.3% of the market. The category includes post-operative knee braces, osteoarthritis unloading braces, ankle supports, shoulder immobilization products, spinal supports, wrist and hand orthoses, functional sports braces, range-of-motion braces, and related rehabilitation supports.

Demand is supported by both surgical and nonsurgical care. More than 53 million adults have diagnosed arthritis, creating a large population for joint stabilization and unloading technologies. Medicare’s revised 2026 knee-orthosis coverage framework for certain patients with tibiofemoral osteoarthritis is particularly important because it recognizes a larger clinically relevant group whose pain or functional limitation may warrant bracing even when traditional instability criteria are not the central issue. Smart braces with Bluetooth connectivity and motion monitoring are raising the revenue ceiling of this category.

Robotic and Computer-Assisted Rehabilitation Systems

Robotic, computer-assisted, and advanced connected rehabilitation systems represented approximately USD 0.82 billion, or 15.0% of the 2026 market. These systems include robotic rehabilitation platforms, sensor-based movement systems, instrumented gait technologies, advanced motion-feedback devices, computer-assisted exercise equipment, and certain wearable rehabilitation technologies.

Although the category remains smaller than traditional exercise equipment, it is positioned for the strongest value growth through 2032. Rehabilitation hospitals, large health systems, orthopedic centers of excellence, sports institutes, and academic centers are the primary buyers because these technologies require greater capital investment and often depend on specialized clinical workflows. Growth will increasingly depend on whether vendors can demonstrate measurable therapist productivity and functional improvement rather than technological novelty alone.

Continuous Passive-Motion and Joint-Mobilization Systems

Continuous passive-motion and related joint-mobilization systems accounted for approximately USD 0.60 billion, or 11.0% of the market in 2026. These systems are primarily used during selected post-operative pathways involving the knee, shoulder, elbow, hand, and other joints. They can support controlled passive movement when active movement is limited or closely managed.

The commercial model increasingly combines device rental, home delivery, patient education, and digital monitoring. Connected CPM platforms can collect utilization information and extend orthopedic oversight into the home. The category faces competition from early active-mobilization protocols, but remains commercially relevant in selected physician-directed procedures and complex recovery pathways.

Gait, Mobility and Body-Weight-Support Rehabilitation Equipment

Gait and mobility-oriented rehabilitation equipment represented approximately 11.4% of the market, equal to USD 0.62 billion in 2026. The segment covers parallel bars, gait-training systems, body-weight-support systems, mobility-training equipment, anti-gravity systems, balance platforms, and medically directed ambulation technologies used to restore safe functional movement.

The category benefits from the aging population, post-operative deconditioning, fracture rehabilitation, lower-extremity weakness, and fall prevention. About one in four U.S. older adults experiences a fall each year, supporting long-term demand for technologies that improve strength, gait confidence, loading tolerance, and functional mobility.

By Application

Osteoarthritis and Degenerative Joint Disease

Osteoarthritis and degenerative joint disease represented the largest application segment at approximately USD 1.55 billion, or 28.4% of the 2026 market. Demand spans exercise therapy, unloading braces, pain-management modalities, strengthening systems, mobility aids, and pre- and post-operative rehabilitation.

The segment’s commercial importance reflects both prevalence and treatment duration. Arthritis becomes substantially more common with age, and adults aged 45 years and older account for the overwhelming majority of diagnosed cases. Because many patients spend years in conservative management before joint replacement, the revenue opportunity exists across repeated rehabilitation episodes rather than at a single intervention point.

Post-Orthopedic Surgery Rehabilitation

Post-operative orthopedic rehabilitation generated approximately USD 1.34 billion in 2026, representing 24.6% of the market. Hip and knee arthroplasty, ligament reconstruction, shoulder repair, spine surgery, fracture fixation, cartilage procedures, and other orthopedic interventions create demand for rehabilitation devices immediately after treatment.

This segment is strategically attractive because care pathways can be standardized around surgical episodes. Providers can prescribe braces, cold and compression therapy, electrical stimulation, CPM, gait equipment, or digital recovery systems before discharge. Ambulatory surgery growth should strengthen the category because patients have less facility-based recovery time and require greater support after returning home.

Spine, Back and Neck Rehabilitation

Spine, back, and neck rehabilitation accounted for approximately USD 0.95 billion, or 17.4% of 2026 market revenue. The segment covers chronic lower-back pain, post-spine-surgery recovery, muscular dysfunction, posture-related impairment, neck pain, work-related injuries, and rehabilitation following spinal degenerative disease.

Back pain has historically been one of the most common musculoskeletal complaints among U.S. adults. Device demand includes electrotherapy, strengthening and stabilization systems, therapeutic exercise equipment, spinal support products, and connected home-recovery solutions. The strongest commercial opportunity lies in combining active rehabilitation with objective adherence monitoring rather than relying solely on passive pain relief.

Sports and Soft-Tissue Injury Rehabilitation

Sports medicine and soft-tissue rehabilitation represented approximately USD 0.69 billion, or 12.7% of the market in 2026. Relevant conditions include ligament injury, muscle strain, tendon injury, meniscal pathology, shoulder instability, ankle injury, overuse conditions, and return-to-sport recovery.

The U.S. market is supported by professional sports, collegiate athletics, high-school sports, recreational activity, and a growing consumer expectation for rapid functional return. Buyers in this category frequently adopt technologies earlier than general community care, particularly force measurement, anti-gravity exercise, connected strength assessment, advanced bracing, and recovery modalities.

Fracture and Orthopedic Trauma Rehabilitation

Fracture and trauma-related rehabilitation represented approximately USD 0.48 billion, or 8.8% of the 2026 market. Lower-extremity fractures, upper-extremity trauma, workplace injuries, fall-related injuries, and motor-vehicle trauma commonly require prolonged restoration of strength, range of motion, and safe ambulation after acute treatment.

Aging demographics increase the importance of this segment because fractures in older adults often lead to prolonged deconditioning and fall risk. Rehabilitation devices that permit controlled loading and safe progressive mobility are particularly valuable in post-acute settings.

Chronic Musculoskeletal Pain and Mobility Impairment

Chronic pain and nonsurgical mobility impairment accounted for approximately USD 0.44 billion, or 8.1% of the market in 2026. While smaller by direct device revenue, this segment reaches an extremely large patient population and supports recurring utilization.

The commercial opportunity is shifting from episodic passive modalities toward integrated self-management, strengthening, activity monitoring, and remotely supervised rehabilitation. Technologies capable of documenting functional improvement will be increasingly attractive to value-focused payers and large provider organizations.

By End User

Outpatient Physical Therapy and Orthopedic Clinics

Outpatient physical therapy and orthopedic clinics were the largest end-user segment, representing approximately USD 1.77 billion, or 32.5% of the market in 2026. The position aligns with the structure of the U.S. rehabilitation workforce, where offices of physical, occupational, and speech therapists are the largest employment setting for physical therapists.

These buyers require high-throughput equipment, manageable capital cost, reliability, compact footprints, and products that can support a wide variety of patients each day. Increasing labor cost is pushing clinics toward technologies that produce repeatable measurements and reduce manual documentation.

Hospitals and Integrated Health Systems

Hospitals and health systems represented approximately USD 1.32 billion, or 24.2% of 2026 revenue. Hospitals remain essential purchasers of rehabilitation equipment for orthopedic service lines, inpatient therapy, trauma care, post-surgical mobilization, and transition-of-care programs.

Integrated delivery networks increasingly standardize devices across facilities and negotiate enterprise contracts. Manufacturers capable of supporting acute care, outpatient rehabilitation, and home recovery under a single commercial relationship have a contracting advantage.

Rehabilitation Hospitals, Skilled Nursing and Post-Acute Facilities

This segment accounted for approximately USD 0.84 billion, or 15.4% of the 2026 market. Patients in these settings often have greater mobility limitations, multiple comorbidities, or more complex functional deficits than routine outpatient populations.

Equipment purchasing emphasizes durability, transfer safety, gait retraining, strengthening, balance improvement, and the ability to serve multiple patients. Labor-saving technologies are attractive because repetitive mobility assistance can create significant staff burden.

Home Healthcare and Patient-Directed Rehabilitation

Home-based musculoskeletal rehabilitation represented approximately USD 0.81 billion, or 14.9% of the market in 2026 and is among the fastest-growing end-user segments.

The home channel benefits from earlier discharge, consumer familiarity with connected devices, home health expansion, telehealth, and remote therapeutic monitoring. Successful home devices must be clinically useful while remaining simple enough for patients or caregivers to operate reliably. Connectivity increasingly differentiates premium products because providers want visibility into adherence without adding unnecessary in-person encounters.

Ambulatory Surgery Centers and Orthopedic Surgical Facilities

ASCs and dedicated orthopedic surgical facilities represented approximately USD 0.43 billion, or 7.9% of the 2026 market. Although the surgical facility may not provide the full rehabilitation episode, it strongly influences which post-operative devices enter the pathway.

Growth in outpatient joint and sports-medicine procedures makes this channel increasingly important for preconfigured recovery bundles, braces, cryotherapy, compression, mobility equipment, and digital post-operative platforms.

Sports Medicine, Athletic Training and Performance Centers

Sports and performance facilities represented approximately USD 0.28 billion, or 5.1% of the market in 2026. These facilities form a comparatively small but innovation-intensive buyer group.

Their willingness to adopt force measurement, advanced strengthening systems, anti-gravity training, dynamic bracing, objective return-to-sport assessment, and connected performance technologies gives them influence disproportionate to their market share.

By Technology Type

Conventional Mechanical Rehabilitation Technologies

Conventional mechanical systems remained the largest technology category at approximately USD 2.07 billion, representing 38.0% of the 2026 market. Exercise devices, mechanical braces, resistance systems, treatment tables, balance products, CPM equipment, and conventional mobility-training systems make up the core of installed rehabilitation infrastructure.

Growth is slower than the total market but remains durable because mechanical rehabilitation cannot be fully replaced by software. The competitive priority is improving ergonomics, footprint, adjustability, durability, and cost of ownership.

Electrotherapy, Thermal and Ultrasound Technologies

Electrotherapy and related physical modalities represented approximately USD 1.32 billion, or 24.2% of the market in 2026. The category benefits from high chronic-pain prevalence and broad clinical familiarity.

Future differentiation will depend on portability, multimodality systems, treatment personalization, usability, and integration between clinic and home care.

Sensor-Enabled and Connected Digital Rehabilitation

Connected rehabilitation technologies generated approximately USD 0.81 billion, or 14.9% of 2026 revenue. This category includes smart braces, connected motion sensors, digital adherence platforms, instrumented exercise devices, remote musculoskeletal monitoring hardware, and rehabilitation technologies linked to provider dashboards.

It is expected to materially outgrow the overall market through 2032 as remote therapeutic monitoring becomes more integrated into physical therapy and orthopedic workflows.

Robotic and Automated Rehabilitation Technologies

Robotic and automated systems accounted for approximately USD 0.68 billion, or 12.5% of 2026 market revenue. These platforms support highly repeatable movement, gait retraining, quantitative assessment, and intensive rehabilitation.

Adoption is concentrated in larger facilities because of capital requirements. Future market expansion depends on lower system cost, broader orthopedic indications, faster patient setup, and stronger evidence demonstrating therapist productivity.

Anti-Gravity and Body-Weight-Support Technologies

Anti-gravity and body-weight-support systems represented approximately USD 0.57 billion, or 10.4% of the market in 2026. These technologies allow patients to begin gait and exercise activity while reducing musculoskeletal loading.

They are particularly relevant in lower-extremity surgery, sports injury, severe deconditioning, obesity-associated joint stress, and complex gait rehabilitation. Increasing interest in early mobilization should sustain premium adoption.

Regional Insights: Where the Market is Growing Fastest

The U.S. Musculoskeletal Rehabilitation Devices Market is geographically divided into the South, West, Midwest, and Northeast. Regional performance reflects population, age structure, orthopedic procedure activity, physical therapy capacity, hospital and ASC density, payer mix, sports participation, rural access, and adoption of home rehabilitation.

The South was the largest regional market in 2026, while the West is positioned to record the fastest growth through 2032. The Northeast maintains a high-value clinical profile because of specialist and academic medical center density, while the Midwest offers a durable mix of orthopedic demand, mature rehabilitation infrastructure, and major medical-device manufacturing capability.

South

The South accounted for approximately USD 1.96 billion, or 36.0% of the U.S. market in 2026, and is projected to reach around USD 3.52 billion by 2032, corresponding to a regional CAGR of approximately 10.25%.

The region encompasses Alabama, Arkansas, Delaware, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia. The broader Census South also includes the District of Columbia.

Texas and Florida are the two most strategically important state markets. Texas had more than 31.7 million residents in 2025, making it the second-largest state population in the nation. Houston, Dallas-Fort Worth, Austin, and San Antonio support major orthopedic networks, large integrated health systems, sports-medicine infrastructure, and expanding ambulatory surgery capacity. Population growth also expands the commercially insured rehabilitation pool.

Florida had approximately 23.46 million residents in 2025, with roughly 22.8% aged 65 years or older. This creates one of the strongest demographic combinations in the country for osteoarthritis rehabilitation, joint-replacement recovery, mobility training, fall-prevention equipment, pain-management devices, and home rehabilitation.

North Carolina and Georgia are becoming increasingly important because each now exceeds 11 million residents and continues to gain population. Charlotte, Raleigh-Durham, Atlanta, and surrounding metropolitan markets support expanding orthopedic practices and outpatient rehabilitation networks. Tennessee has established orthopedic and sports-medicine clusters, while Virginia and Maryland provide high-income metropolitan markets with sophisticated health systems.

Alabama, Arkansas, Kentucky, Louisiana, Mississippi, Oklahoma, South Carolina, and West Virginia combine meaningful musculoskeletal disease burden with larger rural populations. These states are particularly attractive for portable home technologies and remote supervision because patients outside metropolitan areas may face longer travel distances to specialty rehabilitation.

The South’s growth advantage therefore comes from a combination of absolute population scale, migration, aging, high orthopedic disease burden, ASC development, and the commercial need to decentralize recovery.

West

The West represented approximately USD 1.31 billion, or 24.0% of market revenue in 2026, and is projected to reach approximately USD 2.43 billion by 2032, making it the fastest-growing region at around 10.85% CAGR.

The region includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.

California is the region’s anchor market, with approximately 39.36 million residents in 2025, the largest state population in the country. It combines large hospital networks, academic orthopedic institutions, sports-medicine demand, rehabilitation chains, technology companies, venture-backed digital health developers, and a population receptive to connected care. California is especially attractive for sensor-enabled rehabilitation, home recovery platforms, movement analytics, and premium outpatient technology.

Arizona is a particularly important musculoskeletal rehabilitation market because its 2025 population exceeded 7.62 million and approximately 20.6% of residents are aged 65 years or older. The combination of older demographics and population growth supports joint rehabilitation, bracing, gait training, physical therapy, and pain-management demand.

Washington exceeded 8 million residents in 2025 and provides a technologically sophisticated provider market. Colorado and Utah combine strong sports participation, active populations, and growing metropolitan health systems, supporting both clinical rehabilitation and return-to-sport technologies.

Nevada, Idaho, and Utah have recorded strong population expansion, which is increasing the number of orthopedic practices, outpatient facilities, and physical therapy clinics. Oregon maintains a well-developed rehabilitation culture, while Alaska, Montana, Wyoming, New Mexico, and Hawaii present geographic-access challenges that strengthen the use case for home-based and remotely supported devices.

The West is likely to gain national market share because the next growth cycle increasingly favors connected, software-enabled, outpatient, and patient-operated rehabilitation technologies.

Northeast

The Northeast generated approximately USD 1.04 billion, or 19.1% of the market in 2026, and is projected to reach approximately USD 1.74 billion by 2032, reflecting a CAGR near 8.96%.

The region includes Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, and Pennsylvania.

New York remains the largest state market, with a population of approximately 20.0 million in 2025. New York City and major upstate health systems support large orthopedic surgery, rehabilitation, sports medicine, and post-acute care volumes. Pennsylvania, with more than 13 million residents, provides another large clinical base, while New Jersey exceeds 9.5 million residents and benefits from dense suburban orthopedic and therapy networks.

Massachusetts has a smaller population of about 7.15 million but punches above its demographic weight because of its concentration of academic hospitals, biomedical research, specialist practices, and early clinical adoption. Connected rehabilitation and advanced motion-analysis technologies can gain influential reference customers in the Boston healthcare ecosystem.

Maine is particularly relevant to musculoskeletal rehabilitation because approximately 24.6% of its population is aged 65 years or older, among the highest shares nationally. Vermont and New Hampshire have similar aging considerations, although smaller populations limit total commercial scale.

The Northeast is unlikely to match the South or West for volume growth, but it remains important for premium product adoption, evidence generation, academic partnerships, and complex orthopedic care.

Midwest

The Midwest represented approximately USD 1.14 billion, or 20.9% of the 2026 market, and is projected to reach approximately USD 1.89 billion by 2032, corresponding to an approximately 8.79% CAGR.

The region includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota.

Illinois, Ohio, and Michigan form the largest population centers. Illinois had approximately 12.72 million residents in 2025, Ohio around 11.90 million, and Michigan more than 10.12 million. Chicago, Cleveland, Columbus, Cincinnati, Detroit, and other metropolitan markets support substantial orthopedic, sports-medicine, and rehabilitation networks.

Minnesota is strategically significant because of its medical-device ecosystem and concentration of healthcare expertise. Wisconsin, Indiana, and Missouri support large community-provider networks and strong orthopedic procedure demand. Iowa, Kansas, Nebraska, North Dakota, and South Dakota have lower absolute patient volumes but present attractive opportunities for remote rehabilitation because of rural geography and regional referral patterns.

The Midwest’s market character favors clinically proven, durable, cost-efficient technologies. Buyers often place greater emphasis on service reliability, total ownership cost, and practical workflow benefits than on technology novelty alone. Vendors able to demonstrate measurable productivity or reduce the need for avoidable travel can perform particularly well.

Key Market Players

The U.S. musculoskeletal rehabilitation devices competitive environment is fragmented across orthopedic bracing, electrotherapy, rehabilitation equipment, connected recovery, post-surgical devices, mobility technology, and physical therapy distribution. Unlike orthopedic implants, no single manufacturer controls the full rehabilitation continuum.

Some of the approximately 15 highly relevant market participants are:

Enovis Corporation / DonJoy / Chattanooga
Breg, Inc.
Össur
Ottobock
Zynex, Inc.
Dynatronics Corporation
Performance Health
Biodex Medical Systems
Richmar / Compass Health Brands
Kinex Medical Company
Lifeward Ltd. / AlterG
DIH Technology / Hocoma
Avanos Medical / Game Ready
Medline Industries
Drive DeVilbiss Healthcare

Enovis has a particularly strong position because its prevention-and-recovery portfolio spans orthopedic bracing, rehabilitation technologies, bone-growth stimulation, electrotherapy, and digital orthopedic recovery. Breg combines bracing with integrated DME workflow capabilities and access to thousands of orthopedic providers. Össur and Ottobock have deep expertise in orthotics, mobility, and advanced biomechanical support.

Dynatronics, Richmar, Performance Health, and Biodex are strongly aligned with the physical therapy channel. Their competitive advantage comes from clinician familiarity, modality breadth, distribution reach, and installed equipment relationships. Kinex is important in post-operative home rehabilitation and CPM. Avanos participates through Game Ready’s cold and compression recovery technology.

Lifeward’s AlterG platform and DIH/Hocoma represent the higher-technology end of rehabilitation, where differentiation comes from advanced gait, loading, and robotic systems rather than commodity equipment. Medline and Drive DeVilbiss benefit from broad healthcare distribution and mobility-product reach.

Competitive share through 2032 will increasingly be influenced by clinical evidence, reimbursement support, digital interoperability, patient adherence, provider workflow integration, supply reliability, service infrastructure, and ability to demonstrate economic value per recovery episode.

Recent Developments

The most commercially important recent change is the formalization of musculoskeletal remote therapeutic monitoring within the U.S. rehabilitation reimbursement environment. For 2026, CMS added new remote therapeutic monitoring codes that include device supply for shorter monitoring durations and treatment-management time. The musculoskeletal-specific coding framework strengthens the economic model for connected orthopedic rehabilitation because clinicians can incorporate device-generated adherence and response data into a reimbursable care pathway.

CMS also set the 2026 KX modifier threshold for outpatient rehabilitation therapy at USD 2,480, illustrating the continued importance of utilization management and documentation in Medicare therapy. Physical therapists, occupational therapists, and other eligible clinicians increasingly need to demonstrate medical necessity while managing the economics of repeated therapy encounters. Objective device data can become strategically valuable in this environment.

Another major development is the 2026 revision of Medicare’s Knee Orthoses Local Coverage Determination. Effective January 25, 2026, coverage criteria were modified for certain single- or double-upright knee orthoses used by ambulatory Medicare beneficiaries with documented medial or lateral tibiofemoral osteoarthritis and qualifying pain or reduction in mobility and function. This improves the addressable reimbursement pathway for clinically appropriate OA bracing.

Technology development is also increasingly connecting physical devices with digital recovery workflows. Smart post-operative braces now combine controlled range-of-motion support with sensors, mobile applications, and provider dashboards. This architecture can help clinicians track movement and compliance outside scheduled visits.

Home orthopedic recovery systems are undergoing a similar transition. Connected joint-mobilization platforms, portable stimulation, digital exercise guidance, and monitoring tools allow patients to complete more of their recovery outside conventional therapy facilities. The most successful systems are likely to complement rather than replace physical therapists by making between-visit activity visible.

The U.S. rehabilitation supply chain is also evolving around faster distribution and point-of-care availability. Large rehabilitation suppliers are expanding regional fulfillment capabilities, reflecting growing demand from outpatient clinics, home care, post-acute providers, and healthcare systems that expect rapid product availability without holding excessive inventory.

Finally, innovation is increasingly moving toward recovery pathways rather than standalone SKUs. Manufacturers are combining braces, rehabilitation hardware, applications, adherence tracking, patient education, and provider workflow tools. This transition is likely to make software and data capability an increasingly important source of differentiation even when the physical device itself is relatively mature.

Conclusion

The U.S. Musculoskeletal Rehabilitation Devices Market Size & Share is positioned to expand from USD 5.45 billion in 2026 to approximately USD 9.58 billion by 2032, representing a 9.85% CAGR during 2027–2032.

Historical growth from USD 4.18 billion in 2023 to USD 4.96 billion in 2025 reflects a market already benefiting from recovering orthopedic procedural activity, aging demographics, outpatient physical therapy growth, home rehabilitation, and increasing use of connected recovery technologies.

The industry’s fundamental strength comes from the breadth of its patient population. More than 53 million U.S. adults live with diagnosed arthritis, almost one-quarter of adults report chronic pain, millions of orthopedic procedures require post-operative recovery, and age-related mobility limitations are increasing the clinical importance of strength, balance, gait, and fall-prevention rehabilitation.

The largest current revenue opportunities remain therapeutic exercise, electrotherapy, orthopedic rehabilitation bracing, osteoarthritis management, post-surgical recovery, and outpatient physical therapy. However, the greatest incremental value creation through 2032 is expected in connected rehabilitation, smart braces, sensor-enabled home recovery, remote therapeutic monitoring, robotic rehabilitation, and advanced weight-support technologies.

The commercial model is also changing. U.S. buyers increasingly evaluate rehabilitation technologies through their impact on the entire orthopedic episode. A device that improves adherence, accelerates safe mobility, enables earlier discharge, reduces repetitive therapist labor, supports remote monitoring, or decreases avoidable utilization can generate economic value beyond its purchase price.

Regionally, the South will remain the largest market, driven by Texas, Florida, North Carolina, Georgia, and rapidly expanding Sun Belt healthcare infrastructure. The West is expected to grow fastest, led by California’s innovation ecosystem and population expansion across Arizona, Washington, Nevada, Utah, and Idaho. The Northeast will remain important for premium clinical adoption and academic influence, while the Midwest will continue to provide a stable, evidence-oriented rehabilitation market with substantial orthopedic procedure demand.

For manufacturers, investors, distributors, healthcare systems, and market-entry teams evaluating this industry, the decisive question is no longer whether U.S. rehabilitation demand will expand. The key strategic questions are which devices can move recovery safely into lower-cost settings, which platforms can generate clinically usable data, which technologies align with Medicare and commercial reimbursement, and which manufacturers can prove measurable economic improvement across the musculoskeletal care episode.

Companies that combine strong physical-device design with clinical evidence, patient usability, reimbursement understanding, digital connectivity, dependable distribution, and measurable recovery outcomes will be best positioned to capture the next phase of the U.S. musculoskeletal rehabilitation devices market.